DeepMed Research

Vall d'Hebron Research Institute

🇪🇸Spain

Country: 🇪🇸Spain

Ownership: Private

Established: 1994-01-01

Employees: 1K

Market Cap: -

Website: http://www.vhir.org

Clinical Trials

Optimized Treatment Strategy for HighGrade1 (HGT1) Bladder Cancer Based on Substaging: a Prospective Observational Cohort Study

Completed

Conditions: Bladder Cancer

First Posted Date: 2014-04-14

Last Posted Date: 2014-04-14

Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Target Recruit Count: 200

Registration Number: NCT02113501

Locations: 🇪🇸
Hospital Vall d'Hebron, Barcelona, Spain, Barcelona, Spain

Breast Cancer During Pregnancy

Conditions: Pregnancy
Breast Cancer

First Posted Date: 2014-04-02

Last Posted Date: 2014-04-02

Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Target Recruit Count: 30

Registration Number: NCT02102282

Locations: 🇪🇸
Hospital Vall d'Hebron, Barcelona, Spain

Clinical Trial to Measure the Maximun HR After ReConnect ® Supplementation vs. Placebo in CFS.

Phase 2

Completed

Conditions: Chronic Fatigue Syndrome

Interventions: Dietary Supplement: ReConnect (NADH plus CoQ10)
Dietary Supplement: placebo

First Posted Date: 2014-02-14

Last Posted Date: 2015-02-19

Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Target Recruit Count: 80

Registration Number: NCT02063126

Locations: 🇪🇸
Vall Hebron University Hospital, Barcelona, Spain

Chronic Low Back Pain: A Multidisciplinary Approach

Not Applicable

Completed

Conditions: Chronic Pain

Interventions: Other: Physiotherapy
Behavioral: Intervention 2
Other: Intervention 1

First Posted Date: 2013-11-25

Last Posted Date: 2015-06-16

Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Target Recruit Count: 66

Registration Number: NCT01993355

Locations: 🇪🇸
Hospital Universitari Vall d'Hebron Institut de Recerca Vall d'Hebron, Barcelona, Spain

Effectiveness of Psycho-emotional Support in Acute Spinal Cord Injury. ESPELMA Project

Not Applicable

Completed

Conditions: Spinal Cord Injury, Acute
Professional-Patient Relations
Satisfaction
Patient Non-Compliance
Sensitivity Training Groups

Interventions: Behavioral: Training for professionals (Spinal Cord Injury Unit staff).

First Posted Date: 2013-07-01

Last Posted Date: 2015-06-16

Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Target Recruit Count: 90

Registration Number: NCT01889940

Locations: 🇪🇸
Hospital Universitari Vall d'Hebron, Barcelona, Spain

Effect of Supplementation With Vitamin D on the Acute Bronchitis Prevention During the First Year of Life

Phase 3

Completed

Conditions: Acute Bronchitis
Upper Respiratory Tract Infection
Acute Bronchiolitis

Interventions: Drug: Vitamin D3
Drug: Placebo

First Posted Date: 2013-06-12

Last Posted Date: 2017-03-22

Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Target Recruit Count: 200

Registration Number: NCT01875757

Locations: 🇪🇸
Hospital Universitary Vall d'Hebron, Barcelona, Spain

STELLA Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian Cancer

Not Applicable

Completed

Conditions: Ovarian Neoplasms
Endometrial Neoplasms

Interventions: Procedure: Extraperitoneal laparoscopic aortic lymphadenectomy
Procedure: Transperitoneal laparoscopic aortic lymphadenectomy

First Posted Date: 2013-03-14

Last Posted Date: 2015-04-29

Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Target Recruit Count: 60

Registration Number: NCT01810874

Locations: 🇪🇸
Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona, Bacelona, Barcelona, Spain

Multicentric Comparative Randomized Study of the Single-incision Sling Ajust® Versus Suburethral Transobturator Slings.

Not Applicable

Completed

Conditions: Female Stress Urinary Incontinence

Interventions: Device: Ajust sling
Device: Classical transobturator sling

First Posted Date: 2012-10-03

Last Posted Date: 2017-03-28

Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Target Recruit Count: 60

Registration Number: NCT01699425

Locations: 🇪🇸
Hospital de Palamós, Palamós, Girona, Spain
🇪🇸
Hospital Universitari Vall d'Hebron, Barcelona, Spain
🇪🇸
Hospital Universitari de Girona Dr. Josep Trueta, Girona, Spain

and more 2 locations

Effects of the Administration of Ornithine Phenylacetate in Patients With Cirrhosis and Upper Gastrointestinal Bleeding

Phase 2

Completed

Conditions: Gastrointestinal Bleeding
Cirrhosis

Interventions: Drug: Ornithine-phenylacetate

First Posted Date: 2011-09-14

Last Posted Date: 2015-03-24

Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Target Recruit Count: 48

Registration Number: NCT01434108

Locations: 🇪🇸
Hospital Vall Hebron, Barcelona, Spain

Study To Evaluate The Safety And Efficacy Of Lenalidomide For Refractory Cutaneous Lupus

Phase 4

Completed

Conditions: Cutaneous Lupus

Interventions: Drug: Lenalidomide

First Posted Date: 2011-08-03

Last Posted Date: 2011-08-03

Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Target Recruit Count: 15

Registration Number: NCT01408199

Locations: 🇪🇸
Vall D'Hebron Hospital, Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy